Ampio adds new hospitals in trial for inhalation treatment of COVID-19

Ampio adds new hospitals in trial for inhalation treatment of COVID-19

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced the addition of two new study sites to further the expansion of its ongoing U.S. Phase I clinical trial for inhalation... Read More

Wednesday February 24, 2021 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, Mike Macaluso, COVID-19

Cytocom updates investigational new drug application for phase 2 clinical trial of CYTO-205 for treatment of COVID-19

Cytocom updates investigational new drug application for phase 2 clinical trial of CYTO-205 for treatment of COVID-19

FORT COLLINS -- Cytocom, Inc. today provided an update regarding its CYTO-200 portfolio of clinical programs. Cytocom said it has submitted an Investigational New Drug (IND) application with... Read More

Tuesday February 16, 2021 0 comments Tags: Fort Collins, Cytocom, COVID-19, CYTO-205, Michael Handley

BurstIQ deploys proprietary blockchain-enabled technology to securely track COVID-19 vaccination efforts

BurstIQ deploys proprietary blockchain-enabled technology to securely track COVID-19 vaccination efforts

DENVER -- BurstIQ announced their proprietary blockchain-enabled network will help streamline COVID-19 testing, vaccine administration and tracking. BurstIQ has partnered with a consortium of... Read More

Thursday February 11, 2021 0 comments Tags: Denver, BurstIQ, Frank Ricotta, COVID-19

Biodesix publishes data on new COVID-19 artificial intelligence-based algorithm for use in clinical decision support systems

Biodesix publishes data on new COVID-19 artificial intelligence-based algorithm for use in clinical decision support systems

BOULDER -- Biodesix, Inc. (Nasdaq: BDSX) today announced a publication describing the development of a new AI-based COVID-19 algorithm and important data from a related study. The paper,... Read More

Tuesday February 9, 2021 0 comments Tags: Boulder, Biodesix, Scott Hutton, COVID-19

New COVID-19 antibody test receives emergency use authorization by FDA

New COVID-19 antibody test receives emergency use authorization by FDA

DENVER --Scientists at the University of Denver have tested a new antibody test for COVID-19 that can predict if a patient will experience mild versus more severe symptoms of the virus. The... Read More

Thursday February 4, 2021 0 comments Tags: Denver, University of Denver, COVID-19, FDA, Jeremy Haefner

Ampio announces early positive data in Phase 1 trial of inhaled Ampion in treating COVID-19 distress

Ampio announces early positive data in Phase 1 trial of inhaled Ampion in treating COVID-19 distress

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE American: AMPE) announced early positive data from its ongoing U.S. Phase I controlled, observer-blinded clinical trial of inhaled Ampion versus... Read More

Tuesday February 2, 2021 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, COVID-19

BioIntelliSense and American College of Cardiology join to advance remote cardiac care

BioIntelliSense and American College of Cardiology join to advance remote cardiac care

DENVER -- BioIntelliSense, Inc. announced the company has formed a strategic collaboration with the American College of Cardiology (ACC) that combines innovative medical-grade wearable devices and... Read More

Tuesday January 12, 2021 0 comments Tags: Denver, BioIntelliSense, James Mault, BioButton, COVID-19, American College of Cardiology

Ampio provides update on clinical trials for Ampion treatment of COVID-19

Ampio provides update on clinical trials for Ampion treatment of COVID-19

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced an update on the launch of a new global clinical trial for intravenous treatment of COVID-19 with Ampion and provided updates... Read More

Tuesday January 5, 2021 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, Michael Macaluso, COVID-19